Variant #0000456019 (NC_000016.9:g.2137898C>T, NM_000548.3:c.5024C>T (TSC2))
| Chromosome |
16 |
| Allele |
Unknown |
| Affects function (as reported) |
Affects function |
| Affects function (by curator) |
Not classified |
| Classification method |
- |
| Clinical classification |
NA |
| DNA change (genomic) (Relative to hg19 / GRCh37) |
g.2137898C>T |
| DNA change (hg38) |
g.2087897C>T |
| Published as |
- |
| ISCN |
- |
| DB-ID |
TSC2_000033 See all 63 reported entries |
| Variant remarks |
TSC2 signals significantly reduced compared to wild-type TSC2 indicating aa change destabilises TSC2 causing accelerated degradation of variant; mean T389/S6K ratio of variant significantly higher than that of wild-type TSC2 and not different from that of pathogenic TSC2 p.R611Q indicating variant was less effective at inhibiting TORC1 |
| Reference |
PubMed: Hoogeveen-Westerveld, 2013 |
| ClinVar ID |
- |
| dbSNP ID |
- |
| Origin |
In vitro (cloned) |
| Segregation |
- |
| Frequency |
- |
| Re-site |
- |
| VIP |
- |
| Methylation |
- |
| Average frequency (gnomAD v.2.1.1) |
Retrieve |
| Owner |
Rosemary Ekong |
| Database submission license |
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International |
| Created by |
Rosemary Ekong |
| Date created |
2013-06-12 02:25:54 +02:00 (CEST) |
| Date last edited |
2021-04-23 13:58:39 +02:00 (CEST) |

Variant on transcripts
|